C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction Leicester Acute Myocardial Infarction Peptide (LAMP) Study
作者： Sohail Q. Khan , Onkar S. Dhillon , Russell J. O’Brien , Joachim Struck , Paulene A. Quinn
DOI: 10.1161/CIRCULATIONAHA.106.685503
关键词:
摘要: Background— The role of the vasopressin system after acute myocardial infarction is unclear. Copeptin, C-terminal part prohormone, secreted stoichiometrically with vasopressin. We compared prognostic value copeptin and an established marker, N-terminal pro-B-type natriuretic peptide (NTproBNP), infarction. Methods Results— In this prospective single-hospital study, we recruited 980 consecutive post–acute patients (718 men, median [range] age 66 [24 to 95] years), follow-up over 342 (range 0 764) days. Plasma was highest on admission (n=132, P<0.001, day 1 versus days 2 5) reached a plateau at 3 5. patients, (measured elevated in who died (n=101) or were readmitted heart failure (n=49) survivors (median 18.5 [0.6 441.0] 6.5 [0.3 267.0] pmol/L, P<0.0005). With logistic regression analysis, (odds rat...
sci-hub.se 参考文章(24)
Jun Fukuzawa, Takashi Haneda, Kenjiro Kikuchi, Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor. Molecular and Cellular Biochemistry. ,vol. 195, pp. 93- 98 ,(1999) , 10.1023/A:1006980517557
F. M. de Bree, J. P. H. Burbach, Structure-function relationships of the vasopressin prohormone domains. Cellular and Molecular Neurobiology. ,vol. 18, pp. 173- 191 ,(1998) , 10.1023/A:1022564803093
Dirk A. Holwerda, A Glycopeptide from the Posterior Lobe of Pig Pituitaries FEBS Journal. ,vol. 28, pp. 334- 339 ,(1972) , 10.1111/J.1432-1033.1972.TB01918.X
Marc S. Sabatine, David A. Morrow, James A. de Lemos, C. Michael Gibson, Sabina A. Murphy, Nader Rifai, Carolyn McCabe, Elliott M. Antman, Christopher P. Cannon, Eugene Braunwald, Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide Circulation. ,vol. 105, pp. 1760- 1763 ,(2002) , 10.1161/01.CIR.0000015464.18023.0A
Elliott Antman, Jean-Pierre Bassand, Werner Klein, Magnus Ohman, Jose Luis Lopez Sendon, Lars Rydén, Maarten Simoons, Michal Tendera, Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. ,vol. 36, pp. 959- 969 ,(2000) , 10.1016/S0735-1097(00)00804-4
William T Abraham, Alireza A Shamshirsaz, Kim McFann, Ron M Oren, Robert W Schrier, None, Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients Journal of the American College of Cardiology. ,vol. 47, pp. 1615- 1621 ,(2006) , 10.1016/J.JACC.2005.11.071
Gary L. Robertson, Ermelinda A. Mahr, Shahid Athar, Tushar Sinha, Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma Journal of Clinical Investigation. ,vol. 52, pp. 2340- 2352 ,(1973) , 10.1172/JCI107423
Leong L. Ng, Ian Loke, Joan E. Davies, Kamlesh Khunti, Margaret Stone, Keith R. Abrams, Derek T. Chin, Iain B. Squire, Identification of previously undiagnosed left ventricular systolic dysfunction: Community screening using natriuretic peptides and electrocardiography European Journal of Heart Failure. ,vol. 5, pp. 775- 782 ,(2003) , 10.1016/S1388-9842(03)00154-5
Tom D.J. Smilde, Dirk J. van Veldhuisen, Gerjan Navis, Adriaan A. Voors, Hans L. Hillege, Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction Circulation. ,vol. 114, pp. 1572- 1580 ,(2006) , 10.1161/CIRCULATIONAHA.105.610642
Russell J. O'BRIEN, Bettina DEMME, Joan E. DAVIES, Leong L. NG, Iain B. SQUIRE, N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clinical Science. ,vol. 107, pp. 309- 316 ,(2004) , 10.1042/CS20040087